These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9267564)

  • 1. Morphometric analysis in prognostic evaluation of stage I thick cutaneous melanomas.
    Mauri MF; Boi S; Micciolo R; Cristofolini M; Dalla Palma P
    Anal Quant Cytol Histol; 1997 Aug; 19(4):311-5. PubMed ID: 9267564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
    Talve L; Kainu J; Collan Y; Ekfors T
    Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant prognostic value of nuclear morphometry in stage I malignant melanoma of the skin. A multivariate analysis.
    Baak JP; Tan GJ
    Anal Quant Cytol Histol; 1986 Sep; 8(3):241-4. PubMed ID: 3778616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
    Talve LA; Collan YU; Ekfors TO
    J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.
    Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti G; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Paoli S; Bottoni U; Lo Scocco G; Scalvenzi M; Giannotti B
    Dermatol Surg; 2004 Nov; 30(11):1371-5; discussion 1375-6. PubMed ID: 15522016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period.
    Sørensen FB
    Cancer; 1989 May; 63(9):1784-98. PubMed ID: 2702586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions and image analysis nuclear morphometry of small cell (nevoid) melanoma.
    Kossard S; Wilkinson B
    J Cutan Pathol; 1995 Apr; 22(2):132-6. PubMed ID: 7560345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
    Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
    Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karyometric findings and prognosis of stage I cutaneous malignant melanomas.
    Lindholm C; Hofer PA; Jonsson H
    Acta Oncol; 1988; 27(3):227-33. PubMed ID: 3415851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuclear volume in metastasizing "thick" melanomas.
    Mossbacher U; Knollmayer S; Binder M; Steiner A; Wolff K; Pehamberger H
    J Invest Dermatol; 1996 Mar; 106(3):437-40. PubMed ID: 8648173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic features of vulvar melanoma: a clinicopathologic analysis.
    Johnson TL; Kumar NB; White CD; Morley GW
    Int J Gynecol Pathol; 1986; 5(2):110-8. PubMed ID: 3721696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive cutaneous melanoma in elderly patients.
    Loggie B; Ronan SG; Bean J; Das Gupta TK
    Arch Dermatol; 1991 Aug; 127(8):1188-93. PubMed ID: 1863077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Findings of computerised nuclear morphometry of papillary thyroid carcinoma in correlation with known prognostic factors.
    Tseleni S; Kavantzas N; Yova D; Alexandratou E; Karydakis V; Gogas J; Davaris P
    J Exp Clin Cancer Res; 1997 Dec; 16(4):401-6. PubMed ID: 9505213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant melanoma].
    Champeau F; Verola O
    Ann Chir Plast Esthet; 1998 Aug; 43(4):411-20. PubMed ID: 9926473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis.
    Massi D; Franchi A; Borgognoni L; Paglierani M; Reali UM; Santucci M
    Virchows Arch; 2002 Jan; 440(1):22-8. PubMed ID: 11942572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.